Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Temodal submitted for approval in E.U.

Jan. 13, 1998

Potent, selective protein tyrosine kinase inhibitors for immune and hyperproliferative disorders

Jan. 13, 1998

Chemogene therapy: a new therapeutic approach on the horizon?

Jan. 13, 1998

CDK inhibitor induces apoptosis and tumor necrosis in a dog with malignant melanoma

Jan. 12, 1998

FDA approves Photofrin for early-stage lung cancer

Jan. 12, 1998

New mycotoxin with antitumor and favorable hematological effects

Jan. 12, 1998

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Merck continues to devote extensive R&D efforts to FTase inhibitors

Jan. 12, 1998

New phosphatase inhibitors from the University of Pittsburgh

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...